Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, et al
Qualquer sintoma persistente, intenso ou inesperado deve motivar a interrupo imediata e a consulta de um profissional de sade
The coprimary end points were the relative change in body weight and a reduction of 5% or more in body weight from baseline to week 68 with cagrilintidesemaglutide as compared with placebo
Using of GX 600 Injection may cause few side effects such as redness, pain, and swelling at the site of injection
doi: 10.1369/jhc.2008.951319, 148 TreesukosolY.MoranT
It is also a significant risk factor for various cardiovascular conditions